Asha Leisser
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 26, 2022
Single-Center Comparison of [64Cu]-DOTAGA-PSMA and [18F]-PSMA PET-CT for Imaging Prostate Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: August 23, 2021
CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication.
Journal: Blood
Published: July 07, 2021
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 26, 2019
Sex-differences in [68Ga]Ga-DOTANOC biodistribution.
Journal: Nuclear medicine and biology
Published: June 22, 2019
[11C]acetate PET as a tool for diagnosis of liver steatosis.
Journal: Abdominal radiology (New York)
Published: April 13, 2018
Hematopoiesis is prognostic for toxicity and survival of 223Radium treatment in patients with metastatic castration-resistant prostate cancer.
Journal: Hellenic journal of nuclear medicine
Published: September 20, 2017
Abdominal, multi-organ, auto-contouring method for online adaptive magnetic resonance guided radiotherapy: An intelligent, multi-level fusion approach.
Journal: Artificial intelligence in medicine
Published: June 16, 2017
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
Journal: EJNMMI research
Published: January 28, 2016
Last Updated: 09/26/2026